TLIS
Geode Capital Management’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,020
| Closed | -$123K | – | 4616 |
|
|
2024
Q2 | $123K | Buy |
14,020
+2,130
| +18% | +$18.8K | ﹤0.01% | 4076 |
|
|
2024
Q1 | $104K | Buy |
11,890
+610
| +5% | +$5.34K | ﹤0.01% | 4150 |
|
|
2023
Q4 | $84.1K | Hold |
11,280
| – | – | ﹤0.01% | 4234 |
|
|
2023
Q3 | $64.9K | Sell |
11,280
-129,250
| -92% | -$743K | ﹤0.01% | 4361 |
|
|
2023
Q2 | $67.5K | Sell |
140,530
-3,886
| -3% | -$1.87K | ﹤0.01% | 4441 |
|
|
2023
Q1 | $70.8K | Hold |
144,416
| – | – | ﹤0.01% | 4440 |
|
|
2022
Q4 | $64K | Sell |
144,416
-330
| -0.2% | -$146 | ﹤0.01% | 4527 |
|
|
2022
Q3 | $98K | Hold |
144,746
| – | – | ﹤0.01% | 4586 |
|
|
2022
Q2 | $117K | Sell |
144,746
-120,158
| -45% | -$97.1K | ﹤0.01% | 4526 |
|
|
2022
Q1 | $373K | Sell |
264,904
-16,661
| -6% | -$23.5K | ﹤0.01% | 4091 |
|
|
2021
Q4 | $1.13M | Sell |
281,565
-21,403
| -7% | -$85.8K | ﹤0.01% | 3656 |
|
|
2021
Q3 | $1.89M | Buy |
302,968
+44,925
| +17% | +$281K | ﹤0.01% | 3370 |
|
|
2021
Q2 | $2.85M | Buy |
258,043
+26,017
| +11% | +$287K | ﹤0.01% | 3159 |
|
|
2021
Q1 | $2.98M | Buy |
+232,026
| New | +$2.98M | ﹤0.01% | 3056 |
|